

Cover Story
ClinicalTrials & Tribulations
By Wenora Johnson, Danielle Ripley-Burgess, Heather Hampel, Folasade (Fola) P. May, Anjee Davis and Richard M. Goldberg
Technological advances are transforming our understanding of cancer, accelerating the evolution of new treatment approaches. In the past decades, researchers deploying new techniques for analyzing DNA have extended our knowledge of inherited genetic abnormalities that can predispose a person to develop colorectal and other cancers.
In Brief


Funding Opportunities
Clinical Roundup


Trending Stories
- Bertagnolli to announce National Cancer Plan that would “align broad societal engagement” to reduce cancer mortality
- How Beth Carner went from six weeks left to live with stage 4 colon cancer to complete remission
- ACT for NIH publishes Mary Lasker biography to use in lobbying for appropriations—Mary would’ve approved
- Lasker Foundation’s Claire Pomeroy: “Mary’s story truly has been an untold story”
- Jed Manocherian grew obsessed with Mary Lasker after starting an NIH lobbying organization
- FDA releases draft guidance aimed at improving oncology clinical trials for accelerated approval